Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus placebo for postoperative agitation prevention in children under general anesthesia
2022-000943-59Phase 4Terminated
- Sponsor
- University Hospital Odense
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative delirium (POD) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: RASS score. Started Nov 2022; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on 2022-000943-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000943-59.